Figure 4A
The compound-target-pathway networks of XKA in the treatment of T2D. (A) The compound-target-pathway network with compounds identified by LC-MS analysis (NCA).
Figure 4A | Acta Pharmacologica Sinica
The compound-target-pathway networks of XKA in the treatment of T2D. (A) The compound-target-pathway network with compounds identified by LC-MS analysis (NCA).
